This site requires javascript. Please turn that on in your browser\'s preferences. How?

Axis Neuromonitoring Axis Neuromonitoring

SURGLASSES received FDA 510(k) Clearance for Caduceus S

By Admin | December 20, 2022

TAICHUNG, TaiwanDec. 19, 2022 /PRNewswire/ -- SURGLASSES announced today that Caduceus S AR Spine Navigation System has received 510(k) clearance from the U.S. Food and Drug Administration and is ready to launch its products into the US market in the first quarter of 2023. Caduceus S is an augmented reality spine navigation system that will require only few-shots of C-arm images to equip the surgeons with AR and pre-surgical planning with trajectories for spine surgery.

Caduceus S is an innovative medical technology with AR has intended use to be used in the complex spine surgeries. The system is designed to allow surgeons to superimpose the 3D spinal anatomy on a patient during surgical procedures. It equipped with multiple trackers and displays preoperative planned trajectories via 3D AR head mounted display.

Dr. Wang, Min – Liang, CEO and founder of Taiwan Main Orthopaedic Biotechnology Co. Ltd., (SURGLASSES) stated "Caduceus S is the cutting-edge technology that will enhance the spine surgical procedures accuracy and solve the complexities of the spine surgeries surgeons face during the...(More)

For more info please read, SURGLASSES received FDA 510(k) Clearance for Caduceus S, by PR Newswire

« Return to ALL NEWS